Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Forest, which went public in 1967, continued to enjoy the greatest amount of success in its core drug development business.
1984: Forest significantly boosts its sales force with the purchase of O'Neal, Jones & Feldman Inc.
1986: Company purchases Aerobid, an antiasthma drug.
In 1989, for instance, Forest acquired UAD Laboratories for $33 million in stock.
Sales increased to $176 million in 1991 as income leapt to approximately $40 million.
Late in 1995 Forest licensed the United States rights for Tiazac from Biovail Corporation, a Toronto firm.
The FDA approved Celexa in July 1998.
Sales during fiscal 2000 totaled less than $5 million.
In October 2001 the company submitted a new drug application (NDA) to the FDA for lercanidipine, another hypertension treatment, which was licensed from Recordati S.p.A., a privately held Italian firm.
Rate Forest Pharmaceuticals Inc's efforts to communicate its history to employees.
Do you work at Forest Pharmaceuticals Inc?
Does Forest Pharmaceuticals Inc communicate its history to new hires?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Bridge Pharmaceuticals | 2000 | $2.3M | 35 | - |
| Daiichi Sankyo | 2005 | $9.0B | 15,348 | 38 |
| PDI | 1987 | $22.0M | 350 | 46 |
| Warner Chilcott | 1968 | $105.1M | 3,000 | - |
| Organon | - | $6.4B | 158 | 128 |
| Endo Pharmaceuticals Inc | 1997 | $2.6B | 385 | 106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1998 | $12.1B | 30,481 | 1,368 |
| Janssen | 1953 | $601.4M | 1,500 | 3 |
| Meda in the US | 2001 | $80.0M | 149 | - |
| Sanofi US | 1973 | $980.0M | 110,000 | 796 |
Zippia gives an in-depth look into the details of Forest Pharmaceuticals Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Forest Pharmaceuticals Inc. The employee data is based on information from people who have self-reported their past or current employments at Forest Pharmaceuticals Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Forest Pharmaceuticals Inc. The data presented on this page does not represent the view of Forest Pharmaceuticals Inc and its employees or that of Zippia.
Forest Pharmaceuticals Inc may also be known as or be related to Forest Pharmaceuticals Inc and Forest Pharmaceuticals Inc.